Cough Against TB (CATB)

Using the sound of a cough to fight a global epidemic

Cough Against TB (CATB)
420,362
Patients screened
Numbers as of September 2026
54,305
Presumptives identified

The Challenge

With nearly one-fourth of the world's tuberculosis (TB) cases occurring in India1, TB remains a key public health priority. The disease is preventable and curable, and outcomes improve substantially when identified early.

Since traditional screening relies mainly on visible symptoms, asymptomatic or minimally symptomatic individuals are often missed, a critical gap, since undiagnosed individuals can unknowingly transmit the disease to 10–15 people each year2.

Our AI Solution

Our AI Solution

Cough Against TB (CATB) is an AI-powered, non-invasive screening application that analyzes cough sounds and symptoms to identify individuals with presumptive pulmonary TB, enabling early detection in both facility and community settings, even offline.

Designed for India's public health ecosystem, CATB works on Android smartphones and extends the reach of India's TB program to the last mile.

How it works

App setup 01

App setup

the healthcare worker installs the app and begins the screening procedure with consent from the individual.

App setup

the healthcare worker installs the app and begins the screening procedure with consent from the individual.

Individual registration 02

Individual registration

a digital record is created for screening and follow-up (age, gender, and other details).

Individual registration

a digital record is created for screening and follow-up (age, gender, and other details).

Symptom assessment and cough recordings 03

Symptom assessment and cough recordings

health workers record TB-related symptoms and capture three cough recordings following all NTEP infection and prevention control measures.

Symptom assessment and cough recordings

health workers record TB-related symptoms and capture three cough recordings following all NTEP infection and prevention control measures.

CATB analyzes cough sounds 04

CATB analyzes cough sounds

an AI model trained on India-specific data analyzes cough sounds alongside symptoms.

CATB analyzes cough sounds

an AI model trained on India-specific data analyzes cough sounds alongside symptoms.

Instant risk flagging and referral 05

Instant risk flagging and referral

the app identifies presumptive or non-presumptive pulmonary TB; presumptive cases are referred for further diagnostic testing.

Instant risk flagging and referral

the app identifies presumptive or non-presumptive pulmonary TB; presumptive cases are referred for further diagnostic testing.

Ni-kshay ID generation and update 06

Ni-kshay ID generation and update

a Ni-kshay ID is generated or updated for referred cases to ensure continuity within the national TB program.

Ni-kshay ID generation and update

a Ni-kshay ID is generated or updated for referred cases to ensure continuity within the national TB program.

Where It's Deployed

Operational since March 2023, developed with India's Central TB Division, Ministry of Health and Family Welfare. Active in 17 states and 103 districts.

21
States

Impact

CATB demonstrates how AI-powered screening, designed around field realities, can strengthen TB detection within public health systems. By identifying presumptive TB cases—including 14–16% of individuals who may not present with typical symptoms—it extends screening beyond conventional symptom-based approaches, supporting earlier detection and stronger linkage to confirmatory diagnosis. With 90% sensitivity, 69% specificity, and an AUROC of 0.887, CATB demonstrates strong screening performance across community and facility settings. By strengthening the reach and efficiency of TB screening, CATB contributes to India’s efforts under the Pradhan Mantri TB Mukt Bharat Abhiyan and SDG 3, including the goal of ending epidemics and advancing universal health coverage.

420,362
Patients screened
54,305
Presumptives identified

Our Other Solutions

HealthVaani

HealthVaani

Read more →
Line Probe Assay

Line Probe Assay

Read more →

Partners

Partner
Partner
Partner
Partner
0%